13.52% institutional ownership 5.13 million shares (12.21% of the float) currently shorted Current borrow fee: 8.6 % Shares available to borrow: 100'000
An unbelievable 72.79% of the daily volume has been shorted on Friday (as reported by FINRA) but despite the heavy efforts of the shorts, the PPS went up 7.80%! The number of available shares for shorting is 100'000 and the borrow fee is 8.6%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...
Market Data 
Markets 
AI
